Have a personal or library account? Click to login
Immune RECIST criteria and symptomatic pseudoprogression in non-small cell lung cancer patients treated with immunotherapy Cover

Immune RECIST criteria and symptomatic pseudoprogression in non-small cell lung cancer patients treated with immunotherapy

Radiology and Oncology
Volume 52 (2018): Issue 4 (December 2018)
By: Martina Vrankar and  Mojca Unk  
Open Access
|Oct 2018

Download Article

Download the full article as a PDF file.

DOI: https://doi.org/10.2478/raon-2018-0037 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 365 - 369
Submitted on: Feb 5, 2018
|
Accepted on: Mar 12, 2018
|
Published on: Oct 18, 2018
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
symptomatic pseudoprogression,
atypical response,
immunotherapy,
lung cancer
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2018 Martina Vrankar, Mojca Unk, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 52 (2018): Issue 4 (December 2018)Next article